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Background: Emotional problems such as anxiety and low mood in children are common, impair everyday
functioning and increase the risk of severe mental health disorders in adulthood. Relatively few children with
emotional health problems are identified and referred for treatment indicating the need to investigate preventive
approaches.
Methods/Design: The study is designed to be a pragmatic cluster randomized controlled trial evaluating the
effectiveness of an efficacious school-based cognitive behavior therapy (CBT) prevention program (FRIENDS) on
symptoms of anxiety and low mood in children 9 to 10 years of age. The unit of allocation is schools which are
assigned to one of three conditions: school-led FRIENDS, health-led FRIENDS or treatment as usual. Assessments will
be undertaken at baseline, 6 months and 12 months. The primary outcome measure is change on the Revised
Child Anxiety and Depression Scale. Secondary outcome measures assess changes in self-esteem, worries, bullying
and life satisfaction. An economic evaluation will be undertaken.
Discussion: As of September 2011, 41 schools have been recruited and randomized. Final 12-month assessments
are scheduled to be completed by May 2013.
Trial Registration: ISRCTN23563048Background
Emotional problems in children are common with com-
munity surveys in the United States and in the United
Kingdom indicating that at any one time up to 8% of
children aged 5 to 16 years will fulfill DSM diagnostic
criteria for a severe anxiety disorder with accompanying
significant impairment. [1,2]. In addition, many more
children experience severe anxiety or depressive symp-
toms that fall below criteria required for a formal diag-
nosis (that is, sub-threshold) but nonetheless have a
significant impact upon everyday functioning. Studies
suggest that during childhood and adolescence approxi-
mately one in five children will experience incapacitating
anxiety or depression [3-5].* Correspondence: p.stallard@bath.ac.uk
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reproduction in any medium, provided the orAnxiety and depression significantly impair everyday
functioning and increase the risk of mental health disor-
ders in adulthood [6-9]. The economic burden asso-
ciated with childhood emotional disorders is not known
although it is expected to be considerable [10]. Although
effective psychological treatments are available, few chil-
dren receive them. The UK National Mental Health Sur-
vey found that over an 18-month period only 22% of
those children with significant mental health disorders
received treatment from specialist child and adolescent
mental health services [11]. In particular, those with
emotional disorders were least likely to have contact
with specialist services. The limited reach and availability
of specialist treatment services alongside a policy shift
toward early intervention has led to a growing interest
in preventative approaches and a move from clinical to
community settings such as schools.
Reviews of school-based emotional health prevention
programs for primary school children have foundLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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targeted/indicated (provided to at-risk children) pro-
grams could be effective [12,13]. Multi-component pro-
grams (that is, programs that teach different skills such
as relaxation, problem solving, and cognitive awareness)
based upon a clear theoretical framework, particularly
cognitive behavior therapy (CBT), and which included
some parental input (for example, training/information),
provide the strongest evidence of effectiveness. The par-
ticular benefits of CBT-based programs were also noted
in a review of school-based anxiety prevention trials
[14]. Although not formally tested, the effects of CBT
programs were marginally larger than non-CBT inter-
ventions, with the median effect size for CBT pro-
grams of 0.57 indicating a moderate effect. However,
there was considerable variation in effect size between
studies, suggesting that although the content is import-
ant, mediating variables such as adherence to program
fidelity, leader rapport, levels of participation and audi-
ence appeal are also important factors that will influ-
ence effectiveness.
Of the school-based CBT preventive programs that
have been developed, the FRIENDS program appears
particularly successful [15]. This was also noted by the
World Health Organization, which identified FRIENDS
as having strong evidence of being effective as a school-
based intervention for anxiety [16]. The program
addresses a number of the issues identified in the
reviews highlighted above. It has a clear theoretical
model, sufficient sessions, age-appropriate materials, en-
joyable and fun activities, a structured leader manual
with detailed session plans, standardized leader training,
on-going supervision to ensure fidelity, a parent session,
and weekly parent contact sheets.
In an initial randomized controlled trial (RCT) in-
volving 489 children aged 10 to 12 years, significant
post-intervention reductions in anxiety were reported
following FRIENDS [17]. Trained teachers and psychol-
ogists were equally effective in delivering the program
[17]. A subsequent study involving 594 children aged
10 to 13 years found significant reductions in anxiety,
which were maintained at 12 months [18,19]. FRIENDS
also had a positive effect upon mood, that is, a reduction
in symptoms of low mood, in the high anxiety group. In
terms of those with more significant problems, 85% of
those in the FRIENDS group who initially scored above
the clinical cut-off for anxiety and low mood were diag-
nosis free at 12 months compared to 31% in the compari-
son group. The effects appear to last with significant
reductions in anxiety being maintained 3 years after
FRIENDS [20]. In addition, comparison between children
aged 9 and 10 years and those aged 14 to16 years showed
that although both age groups benefited from FRIENDS,
the younger group demonstrated the greatest changesin anxiety symptoms [21]. Although these results are
promising, most trials have been undertaken by the pro-
gram developers in Australia and no RCTs of FRIENDS
have been undertaken in the United Kingdom.
Methods/Design
Aim of the study
The study has two primary aims:
1. To examine whether a school-based CBT program
(FRIENDS delivered by either school or health
professionals) is more effective than the usual school
curriculum in reducing symptoms of anxiety and low
mood in 9- and 10-year-old children (secondary
prevention). Total Revised Child Anxiety and
Depression Scale (RCADS) scores at baseline and 6
months will be compared for all children. A
secondary analysis of the 10% of children in each
arm who have the highest total RCADS scores will
be undertaken to determine the effect upon the most
symptomatic children.
2. To examine the effectiveness of FRIENDS in
maintaining good emotional health, that is, to
prevent high levels of anxiety and low mood from
developing (primary prevention). Total RCADS
scores at baseline and 12 months will be compared
for the 90% of children who are not the most highly
symptomatic.
Design
Preventing Anxiety in Children through Education in
Schools (PACES) is a pragmatic cluster randomized
three-arm controlled trial: FRIENDS delivered by health
staff or school staff versus usual school curriculum. The
arms are summarized in Table 1.
Interventions are delivered in schools to whole classes
of children as part of the school curriculum. Assess-
ments are undertaken at baseline, 6 and 12 months.
Participants and eligibility
Interventions are provided as part of the school Per-
sonal, Social and Health Educational (PSHE) curriculum.
All children in participating classes, that is, year 5 (9 and
10 years old) are eligible to participate. Children are in-
eligible if they are not attending school (for example,
long term sickness, excluded, etcetera) or if they do not
participate in PSHE for religious or other reasons.
Ethical approval and consent
The study was approved by the Department for Health
Research Ethics Committee at the University of Bath.
Consent/assent involves three stages. First, eligible
schools were provided with information about the study
and interested head teachers were required to provide
Table 1 Arms of the Preventing Anxiety in Children through Education in Schools (PACES) randomized controlled trial
Study Arm Content Leader Number of staff
Treatment as usual Normal school curriculum School staff 1
School-led FRIENDS Structured CBT program School staff 3
Health-led FRIENDS Structured CBT program Health professional 3
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pate. Second, information was posted to the home ad-
dress of the parents of all eligible children. Parents were
invited to return a form opting out of the study if they
did not wish their child to complete the study assess-
ments. Finally, children were provided with information
about the study and were required to provide signed
assent before completing a baseline assessment. Dual
carer/child consent/assent was therefore required for as-
sessment completion.
The on-going conduct and progress of the trial is
monitored by an independently chaired Data Monitoring
and Ethics Committee (DMEC) and a Trial Steering
Committee (TSC).
School recruitment
A list of 268 primary schools in Bath and North East
Somerset, and in Swindon and Wiltshire was compiled
from Local Authority information. Project information
sheets were sent to the head teachers and meetings
arranged with the 45 (17%) schools who expressed inter-
est. Four schools did not return signed letters confirm-
ing participation before randomization and were
therefore excluded. A total of 41 schools were rando-
mized with one school withdrawing after randomization.
The cohort therefore consisted of 40 schools (1,448 eli-
gible children).
Randomization
Allocation of schools took place once all schools had
been recruited. Balance between trial arms with respect
to key characteristics (school size, number of classes,
numbers of children in year 5 classes, preferred term of
delivery, preferred day of delivery, mixed-year 5 classes
(that is, classes that were year 4 and year 5 combined
and classes that were year 5 and year 6 combined) or
single year 5 classes and level of educational attainment)
was achieved by calculating an imbalance statistic for a
large random sample of possible allocation sequences
[22]. A statistician with no other involvement in the
study randomly selected one sequence from a subset
with the most desirable balance properties.
Intervention
FRIENDS is a manualized cognitive behavior therapy
(CBT) program designed to improve children's emo-
tional health. Each child has their own workbook andgroup leaders have a comprehensive manual specifying
key learning points, objectives, and activities for each
session. The intervention trialed in this study involves
nine, 60-minute weekly sessions delivered to whole
classes of children. Through a range of age-appropriate
fun activities including stories, quizzes, role plays and
games, children learn practical skills to control their
anxiety. They are helped to identify their feelings and to
learn to relax, thereby managing their anxious feelings.
They are helped to identify unhelpful thoughts (anxiety
increasing) and to replace them with more helpful (anx-
iety reducing) thoughts. Finally, they are helped to face
and overcome their problems and challenges rather than
avoid them. Written work is kept to a minimum and
each session uses a variety of different materials and ac-
tivities to engage and maintain the interest of the chil-
dren. Initial training and regular supervision of class
leaders will be provided by an accredited FRIENDS
trainer.
An additional session for parents/carers is conducted
to provide parents with an overview of the program, the
CBT rationale, and the skills the children will learn. In
addition, parents receive a summary sheet detailing the
key learning points of each session and the ideas their
child will be practicing so that they can reinforce and
encourage their use at home.
Study arms
Forty-one schools were randomized to one of the three
conditions; school-led FRIENDS, health-led FRIENDS or
treatment as usual (control). One school in the control
arm withdrew after randomization.
School-led friends
Each participating school will be asked to identify school
staff (class teachers, special educational needs coordina-
tors and/or teaching assistants) to deliver FRIENDS.
These staff members will attend a two-day training event
to familiarize them with the nature, extent and presenta-
tion of anxiety and depression in children and the CBT
model. They will work through each of the FRIENDS
sessions and have opportunities to practice the exercises
and familiarize themselves with the materials and key
learning points.
At each session the school staff will be assisted by two
health professionals external to the school, to ensure
that at least three adults are present in the class during
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responsible for leading the session but for supporting
the school leader. During delivery of the program, bi-
weekly supervision groups will be established to review
session aims and content and address any problems with
implementation.
Health-led friends
This condition will be delivered by health professionals
(Band 6, for example, school nurses, psychology assis-
tants) external to the school (with the class teacher pro-
viding required assistance). These are not mental health
specialists but health professionals with a lower level of
training or expertise. They will receive the same initial
training as specified above and will attend a biweekly
supervision group.
Treatment as usual
In this group, children will participate in the usual PSHE
sessions provided by the school. These sessions will be
planned and led by the class teacher.
In order to more specifically define Personal Social
and Health Education (PSHE) within each school the
head teacher, school PSHE coordinator and/or the year
5 class teacher will participate in a semi-structured inter-
view. This interview will be undertaken at the end of the
school term and will assess whether the school is follow-
ing the national curriculum, what additional interven-
tions might be running in the school and their content.
The interview will determine the PSHE topics covered
by the 9- and 10-year-old children during the study
period, the way they are addressed (dedicated sessions,
integration, circle time, etcetera), the length of time
devoted to the PSHE curriculum and the number of
adults (for example, teachers, assistants, volunteers, trai-
nees) in the classroom.
Outcome measures
All child outcome data are collected by self-completed
questionnaires administered by researchers blind to
the child’s trial allocation. Questionnaires are completed
at school in classes at baseline, at 6 months and at
12 months.
Primary outcome measures
The primary outcome measure notes changes in the
level of symptoms on the Revised Child Anxiety and De-
pression Scale (RCADS) [23]. This is a recent modifica-
tion of the Spence Children’s Anxiety Scale [24], which
was revised to correspond more closely to DSM-IV cri-
teria for anxiety and depression [25]. The 30-item scale
(RCADS-30) assesses anxiety in the areas of social pho-
bia, separation anxiety, obsessive compulsive disorder,
panic disorder and generalized anxiety disorder and alsoassesses major depressive disorder. The RCADS-30 has
good internal consistency, test-re-test stability and good
convergent and divergent validity [26,27].
Secondary outcomes
Children will complete the Rosenberg Self-Esteem Scale
to assess changes in self-worth and acceptance [28]. The
Penn State Worry Questionnaire for Children [29]
assesses the tendency of children to engage in excessive,
generalized and uncontrolled worry. The degree to
which children have bullied others or have been the vic-
tim of bullying, satisfaction with six aspects of everyday
life (school, appearance, family, home, friendships and
health), and overall life satisfaction (subjective well-
being) will be assessed.
Parents will be asked to complete the Strength and
Difficulties Questionnaire (SDQ), a brief, widely used be-
havioral screening questionnaire that assesses emotional
symptoms, conduct problems, hyperactivity and/or in-
attention, peer relationship problems, and prosocial be-
havior [30,31]. The Parent completed Revised Child
Anxiety and Depression Scale (RCADS-30-P) is a 30-
item parent version of the primary outcome measure
completed by children. The RCADS-30-P has high in-
ternal consistency, test-re-test reliability and good con-
vergent and divergent validity [32].
Class teachers will be asked to complete the impact
rating of the Strengths and Difficulties Questionnaire
(SDQ) for all children in their class. This assesses the
teacher perception of whether a child has a problem,
and if so, enquires about chronicity, distress, social im-
pairment and burden.
Outcomes for the economic evaluation
In order to assess cost-utility, all children will complete
the Child Health Utility-9D (CHU-9D) at baseline and at
6 and 12 months [33]. The CHU-9D, a validated meas-
ure of pediatric health-related quality of life, is short
(nine items) and has been specifically developed for use
with children aged 7 to 11 years. The use of the CHU-
9D will allow us to assess how improvements in mental
health (anxiety and depression) translate into changes in
overall health-related quality of life.
For collecting health, social care and educational re-
source use data, structured interviews will be conducted
with a sample of carers/parents for each of 300 children,
with approximately 100 children from each of the three
conditions. All parents will be invited to participate and
they will be offered £20 to cover the cost of their time.
They will complete the Client Receipt of Services Ques-
tionnaire, a structured interview that assesses their
child’s use of social, health and educational services over
the past 6 months [34]. In addition, a screen of parental
health and mental health, assessment of life events and a
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undertaken.
Power calculation
The study was powered to detect a difference between
FRIENDS (Health- and School-led) and usual PSHE.
Based on an intra-cluster correlation coefficient (ICC) of
0.02, 28 pupils per class, 90% consent and 80% retention,
effect sizes in the range of 0.28 to 0.30 SDs are detect-
able with 80% power and 5% two-sided alpha with 45 to
54 schools (that is, 1,134 to 1,360 consenting pupils). A
standardized treatment effect size of 0.3 is equivalent to
an estimated difference on the RCADS-30 of 3.6 points
based on an SD of 12.
Statistical analysis
Data analysis will be undertaken blinded to allocation.
Analysis and presentation of data will be in accordance
with Consolidated Standards of Reporting Trials
(CONSORT) guidelines and in particular the extension
to cluster randomized trials [35]. The primary compara-
tive analyses will be conducted on an intention-to-treat
(ITT) basis with due emphasis placed on confidence
intervals for the between-arm comparisons. Descriptive
student- and class-level statistics will be used to ascertain
any marked imbalance between the arms at baseline.
The primary analysis will employ a mixed effect linear
regression model to compare the active CBT interven-
tions (health- and school-led) versus treatment, adjust-
ing as usual for stratification variables and baseline
score, and taking appropriate account of the hierarchical
nature of the data (repeated measures, children, classes
and schools). Sensitivity analyses making different
assumptions will be conducted to investigate the poten-
tial effects of missing data.
The extent of missing data will be reported and base-
line factors will be compared for completers and non-
completers to assess the extent of any bias that may
result. Analysis will be undertaken using intention to
treat (ITT). The potential for bias, dependent on the ex-
tent of missing data, will be assessed. Using the frame-
work specified by White et al. an appropriate approach
will be used to impute missing values in both outcome
and descriptor variables [36]. A further complete case
analysis may also be undertaken and compared to the
intention to treat results.
Secondary analyses will include: 1) repeating the pri-
mary analysis adjusting for any variables exhibiting
marked imbalance at baseline to examine whether this
influences the findings; 2) comparison of children who
score high (that is, top 10% of total RCADS scores in
each trial arm) and low on anxiety and mood at baseline
(that is, remaining 90%) to examine who most benefits
from these interventions; 3) similar analyses for othersecondary outcomes (using appropriate multi-level mod-
els and adjusting P values for multiple testing); 4) inves-
tigation of process measures such as number of sessions
attended; and 5) investigation of possible treatment
moderators (for example, gender) and mediators (for ex-
ample, school pedagogic orientation). Finally, although
the study is not sufficiently powered to detect a differ-
ence between the two FRIENDS arms (school- and
health-led) an exploratory analysis will be undertaken.
Economic evaluation
The analysis of the cost data, the CHU-9D data and
cost-effectiveness analysis will be conducted according
to current best practice methods for conducting eco-
nomic evaluation alongside trials, [37,38] and specifically
alongside cluster-randomized controlled trials [39]. In-
cremental costs, incremental effects, and where relevant
incremental cost-effectiveness ratios (ICERs) will be esti-
mated, comparing the three conditions. The incremental
cost per unit quality-adjusted life year (QALY) increase
will be estimated. Both unadjusted analyses and adjusted
analyses will be carried out, adjusting for site, mode of
delivery, number of students and number of classes.
Random effects bivariate linear regression models will
be fitted to model cost and effectiveness (QALY) simul-
taneously, allowing for correlation within clusters and
correlation between cost and effectiveness score within
participants [40]. From these models we will estimate:
the mean difference in costs of the three conditions and
corresponding standard error; the mean difference in ef-
fect and corresponding standard error; and, indirectly
via the variance-covariance matrix of the regression
coefficients, the correlation between the mean cost dif-
ference and the mean effect difference. Where the inter-
ventions are estimated to have both higher costs and
greater effectiveness than control, we will use Fieller’s
method to obtain a parametric estimate of the 95%
confidence interval for the ICER and to construct the
cost-effectiveness acceptability curve (CEAC). Both para-
metric and non-parametric bootstrap estimates of the
confidence interval for the ICERs will be estimated.
Study status
The trial started in January 2011 and 41 schools were
randomized although one subsequently withdrew. Base-
line assessments and intervention delivery started in
September 2011 and twelve-month assessments are
scheduled to be completed by May 2013.
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